Anti-Asthmatic Agents

Created

Last Modified

Loading...
Thumbnail Image

Tags

Level of Review

Data Model

Abstract

Concept set intended to identify patients with an exposure to an anti-asthmatic agent.

Funder(s)

Provenance

The Researching COVID to Enhance Recovery (RECOVER) Post-Acute Sequelae of SARS-CoV-2 (PASC) Electronic Health Record (EHR) Cohort Study

Description

This concept set was developed to classify asthma patients in exploratory analysis of patients with asthma with COVID vs. patients without COVID.

Vocabulary

Medication Classification Level

Clinical Subjects Headings

Data Source

Related Phenotype

Related Person

Related Study

The Researching COVID to Enhance Recovery (RECOVER) Post-Acute Sequelae of SARS-CoV-2 (PASC) Electronic Health Record (EHR) Cohort Study
Children's Hospital of Philadelphia; Janssen (United States)
Study to understand, prevent, and treat post-acute sequelae of SARS-CoV-2 (PASC), including Long COVID.

Related Concept Set

Related Code

Related Publications

Creative Commons license

Except where otherwised noted, this item's license is described as a CC-BY Attribution 4.0 License.

Cite this Concept Set

Hirabayashi, K.. (2022, September). Anti-Asthmatic Agents. [Concept Set]. PEDSpace Knowledge Bank. https://hdl.handle.net/20.500.14642/642

Version History

Now showing 1 - 2 of 2
VersionDateSummary
2024-09-24 15:19:37
Modified to be more comprehensive list (including descendants) of combination medications (ICS and LABA), zileuton, theophylline, LTRA, LABA, ICS, SABA and Cromolyn, and asthma injections.
1*
2024-06-10 15:03:37
* Selected version